Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3974-3977

  Butler, Michelle M ^a   Williams, John D ^a   Peet, Norton P ^a   Moir, Donald T ^a   Panchal, Rekha G ^b   Bavari, Sina ^b   Shinabarger, Dean L ^c   Bowlin, Terry L ^a  

^a MICROBIOTIX INC   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c Micromyx   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CIPROFLOXACIN; DAPTOMYCIN; GENTAMICIN; IMIPENEM; INDOLE DERIVATIVE; LEVOFLOXACIN; LINEZOLID; MBX 1066; MBX 1162; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES; STRUCTURE ACTIVITY RELATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE AEROBIC BACTERIA; GRAM-POSITIVE BACTERIA; INDOLES; MICROBIAL SENSITIVITY TESTS;

EID: 77956120372     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00484-10     Document Type: Article

References (8)

1. Brosh, R. M., Jr., J. K. Karow, E. J. White, N. D. Shaw, I. D. Hickson, and V. A. Bohr. 2000. Potent inhibition of Werner and Bloom helicases by DNA minor groove binding drugs. Nucleic Acids Res. 28:2420-2430.
2. Calhoun, J. H., C. K. Murray, and M. M. Manring. 2008. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin. Orthop. Relat. Res. 466:1356-1362.
3. CLSI. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
4. CLSI. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A7: approved standard, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. CLSI. 2006. Performance standards for antimicrobial susceptibility testing, M100-S16: 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Opperman, T. J., J. D. Williams, C. Houseweart, R. G. Panchal, S. Bavari, N. P. Peet, D. T. Moir, and T. L. Bowlin. 2010. Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR. Bioorg. Med. Chem. 18:2123-2130.
7. Panchal, R. G., R. L. Ulrich, D. Lane, M. M. Butler, C. Houseweart, T. Opperman, J. D. Williams, N. P. Peet, D. T. Moir, T. Nguyen, R. Gussio, T. Bowlin, and S. Bavari. 2009. Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. Antimicrob. Agents Chemother. 53:4283-4291.
8. Walsh, F. M., and S. G. Amyes. 2004. Microbiology and drug resistance mechanisms of fully resistant pathogens. Curr. Opin. Microbiol. 7:439-444.